Disease-modifying therapy for MS (Disease-modifying therapy (DMT) for multiple sclerosis)

What is disease-modifying therapy for MS?

Disease-modifying therapies (DMTs) are medicines that act on the immune system to reduce the inflammation that damages nerves in multiple sclerosis. They are the main long-term treatment for the relapsing form of MS, and a small number are licensed for progressive MS.

The aim is to reduce how often relapses happen, reduce new areas of damage seen on MRI scans, and slow the build-up of disability over time. DMTs do not cure MS and do not repair damage that has already happened. They can take up to about six months to reach their full effect.

DMTs come as tablets, injections you give yourself, or drip infusions given in a day unit. They vary a lot in how strongly they work and in their risks. As a rule, the therapies that reduce relapses most also tend to carry higher risks, including a higher chance of infections.

Choosing a DMT is a careful, shared decision that weighs how active your MS is against the risks of each option, your other health, and your pregnancy plans. Most DMTs need regular blood tests and monitoring.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Options at a glance

These are the main approaches described in this guide. The right option depends on the diagnosis, your goals and what your clinician thinks is safe.

Preparing for your treatment

• Bring your MS history, including relapses, current symptoms and any previous DMTs and why they were stopped.
• List all medicines, supplements, allergies and recent infections.
• Expect baseline blood tests before starting, which may include checks for past infections such as the JC virus, hepatitis and chickenpox immunity.
• Ask whether any vaccinations should be given before you start, as live vaccines may not be safe once treatment begins.
• Tell your team if you could become pregnant or are planning a family, as this strongly affects the choice.
• Arrange time for infusion days or for early side effects if relevant.
• Write down your questions about how strong the treatment is and what its specific risks are.

What happens

Before starting, your specialist confirms the type and activity of your MS and chooses, with you, a therapy that balances benefit against risk. You usually have baseline blood tests, and sometimes scans, heart or eye checks, depending on the drug. Some therapies need a check of whether you carry the JC virus, because this affects the risk of a rare brain infection.

Tablets are taken at home; injections are usually self-given after training; infusions are given in a day unit, where you are watched for reactions. The first dose of some drugs is given under closer observation.

After starting, you have regular monitoring — most often blood tests, sometimes MRI scans — to check the treatment is working and to pick up side effects early. You are given clear advice on warning signs to report.

The benefit is judged over months to years, by counting relapses and looking at MRI scans, not by how you feel on any single day. If the treatment is not controlling the disease, or is not tolerated, your specialist may switch you to another.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

The central trade-off is that the therapies which reduce relapses most also tend to carry the highest risks, including a higher chance of serious infection. With some drugs, the risk of the rare brain infection PML depends heavily on whether you carry the JC virus, whether you have had immune-suppressing treatment before, and how long you have been on the drug. Ask exactly which risks apply to your specific therapy, what monitoring is in place, and what symptoms to report straight away.

Published figures to discuss

Both how well a DMT works and its risks vary a great deal by drug and by individual, so trial figures may not match your own situation. The clearest sourced risk is PML with some therapies. For natalizumab, risk is stratified using JC virus antibody status, any previous immune-suppressing treatment, and how long the drug has been taken; the figures below are from expert stratification data and are not a promise for any one person.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

There is no physical recovery from DMT itself, but starting one is a long-term commitment. 'Afterwards' means settling onto the medicine, getting used to any side effects, keeping up monitoring, and judging benefit over months to years.

• Flu-like symptoms or injection-site reactions in the first weeks of some therapies
• Mild infusion reactions during or just after a drip
• Regular blood tests as part of monitoring
• No immediate change in how you feel, since benefit is measured over time
• Catching coughs and colds a little more easily on some treatments

Aftercare

• Take the therapy exactly as prescribed and keep up every required blood test and scan, even when you feel well.
• Report signs of infection promptly — fever, persistent sore throat, cough or feeling very unwell — as these need quick attention on immune-suppressing treatment.
• Learn and act on the warning signs of rare serious problems, including the brain infection PML, and know who to contact.
• Keep vaccinations up to date as advised, and always check before any live vaccine.
• Discuss pregnancy plans with your specialist well before stopping or changing treatment.
• Carry information about your treatment in case you need emergency or dental care.
• Tell any other doctor or pharmacist that you are on a DMT before starting new medicines.
• Attend all monitoring and follow-up, and ask for an earlier review if you are worried.

• Baseline blood tests and any vaccinations arranged before starting
• JC virus and other infection screening results understood, where relevant
• Monitoring schedule (blood tests and scans) written down
• Warning-signs leaflet kept somewhere handy
• Pregnancy plans discussed if relevant
• Treatment card or details to show other clinicians
• MS specialist nurse or infusion unit contact saved

⚠ Get urgent help if…

• New confusion, personality change, worsening clumsiness, weakness or speech problems — could signal the rare brain infection PML; seek urgent advice
• High fever, severe sore throat, breathlessness or feeling very unwell — possible serious infection
• A severe allergic reaction during or after an infusion: swelling, wheeze, rash or feeling faint — call for help immediately
• A widespread rash, blistering or mouth ulcers after a new medicine
• Yellowing of the skin or eyes, very dark urine, or severe tummy pain (possible liver problem)
• A painful blistering rash on one side of the body (shingles)
• Unusual bruising, bleeding or extreme tiredness (possible blood problem)

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result is fewer relapses and fewer new areas of damage on MRI, with side effects you can live with. For many people with relapsing MS, DMTs achieve this, and stronger therapies can give better relapse control for more active disease when the risks are acceptable.

DMTs do not cure MS or repair damage already done, and they cannot guarantee that the disease will not progress. Benefit is judged over months and years, not from how you feel on a single day, and the right choice may change over time. The aim is the best control of disease activity for the lowest acceptable risk.

DMTs are usually continued for as long as they keep working and are tolerated. Some people stay on the same therapy for many years; others switch because of continued disease activity, side effects or changing circumstances such as pregnancy. Decisions about stopping a DMT — for example in older age or after long stability — are individual and should be made with your specialist, as stopping can sometimes allow disease activity to return.

Related tests, treatments or support

DMT is one part of MS care, alongside treating relapses with steroids, managing symptoms such as fatigue and spasms, rehabilitation, and supporting mood and bladder. It is closely linked to vaccination planning and pregnancy planning. Some therapies require coordination with other specialists, for example for heart or eye checks before starting.

Follow-up & long-term care

You should have regular specialist follow-up while on a DMT, including the blood tests and scans that your particular drug requires, with someone clearly responsible for acting on the results. You should have access to an MS specialist nurse, a clear plan for warning signs, and a review of whether the treatment is working — with a switch considered if disease activity continues.

Repeat, follow-on and what comes next

• Switching DMTs is common if disease activity continues or side effects are a problem.
• Treatment may be paused, changed or restarted around pregnancy.
• Monitoring results can trigger a change of therapy even when you feel well.
• After switching, there can be a gap before the new therapy reaches full effect, which needs planning.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• A defined monitoring schedule, with a named person responsible for acting on blood-test and scan results.
• A named MS specialist nurse and a clear contact route for problems.
• A written list of warning signs, including those of PML and serious infection.
• Regular review of whether the therapy is working, with switching considered if not.
• Joined-up planning for vaccinations, pregnancy and any other treatments.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Which therapy is chosen and whether it is a tablet, injection or infusion
• The baseline tests needed before starting, such as blood tests, JC virus and hepatitis screening, and heart or eye checks
• The ongoing blood-test and MRI monitoring the specific drug requires
• Whether infusions are given in a day unit and how often
• Specialist follow-up appointments and MS specialist nurse support
• Treatment of any side effects or infections that arise
• Letters or reports for work, benefits or insurance

• The cost of the therapy itself and how it is delivered
• The baseline tests required before starting and whether they are included
• The schedule and cost of ongoing monitoring blood tests and scans
• Whether infusion-unit time and observation are included
• Whether specialist and MS nurse follow-up are included
• What happens, and what it costs, if the therapy must be switched or a complication occurs
• Who is responsible for monitoring results and acting on them

On the NHS? Disease-modifying therapies are available on the NHS when you meet the clinical criteria; private access is sometimes used, but the same baseline checks and ongoing monitoring are needed wherever the treatment is given.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• How active is my MS, and does that point towards a moderate- or high-efficacy therapy?
• What are the specific risks of the therapy you are recommending, including infection and PML?
• What baseline tests and ongoing monitoring will I need, and who acts on the results?
• Do I need any vaccinations before starting, and are live vaccines a problem afterwards?
• How does this treatment fit with my pregnancy plans?
• What are the warning signs I must report urgently, and who do I contact?
• How and when will we decide whether it is working or needs switching?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for disease-modifying therapy for ms

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: MS Trust — Disease modifying therapies (DMTs) MS Society — Disease modifying therapies (DMTs) NICE NG220 — Multiple sclerosis in adults: management NHS — Treatment for multiple sclerosis Natalizumab PML risk stratification (expert recommendations) — PMC

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.